ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma

European Urology

Volumn 66, Issue 1, 2014, Pages 77-84

  Brooks, Samira A ^a   Brannon, A Rose ^a,b   Parker, Joel S ^a   Fisher, Jennifer C ^a   Sen, Oishee ^a   Kattan, Michael W ^c   Hakimi, A Ari ^b   Hsieh, James J ^b   Choueiri, Toni K ^d   Tamboli, Pheroze ^e   Maranchie, Jodi K ^f   Hinds, Peter ^f   Miller, C Ryan ^a,g   Nielsen, Matthew E ^a,g,h   Rathmell, W Kimryn ^a,g  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h IL   (United States)

Author keywords

Biomarker; ccRCC; Kidney cancer; Prognosis; Renal cell carcinoma; TCGA

Indexed keywords

BIOLOGICAL MARKER; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; CLEARCODE34; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CODE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; ANIMAL; CLASSIFICATION; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETICS; KIDNEY TUMOR; MIDDLE AGED; SEQUENCE ANALYSIS; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK ASSESSMENT; RNA, NEOPLASM; SEQUENCE ANALYSIS, RNA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84902073050     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.035     Document Type: Article

References (25)

1. N.S. Vasudev, P.J. Selby, and R.E. Banks Renal cancer biomarkers: the promise of personalized care BMC Med 10 2012 112
2. L.M. Ellis The role of neuropilins in cancer Mol Cancer Ther 5 2006 1099 1107 (Pubitemid 43881301)
3. S. Goel, D.G. Duda, and L. Xu et al. Normalization of the vasculature for treatment of cancer and other diseases Physiol Rev 91 2011 1071 1121
4. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 2002 38 47 (Pubitemid 37328806)
5. T.M. Wright, A. Brannon, and J. Gordon et al. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma Oncogene 28 2009 2513 2523
6. M. Yao, Y. Huang, and K. Shioi et al. A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma Cancer 123 2008 1126 1132
7. A.R. Brannon, A. Reddy, and M. Seiler et al. Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns Genes Cancer 1 2010 152 163
8. A.R. Brannon, S.M. Haake, and K.E. Hacker et al. Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology Eur Urol 61 2012 258 268
9. M. Seiler, C.C. Huang, S. Szalma, and G. Bhanot ConsensusCluster: a software tool for unsupervised cluster discovery in numerical data Omics 14 2010 109 113
10. TCGA Data Portal Overview. The Cancer Genome Atlas project Web site. https://tcga-data.nci.nih.gov/tcga/
11. The Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 449 2013 43 49
12. G.K. Geiss, R.E. Bumgarner, and B. Birditt et al. Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325 (Pubitemid 351355126)
13. R. Tibshirani, T. Hastie, B. Narasimhan, and G. Chu Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc Natl Acad Sci U S A 99 2002 6567 6572 (Pubitemid 34526173)
14. J.S. Parker, M. Mullins, and M.C. Cheang et al. Supervised risk predictor of breast cancer based on intrinsic subtypes J Clin Oncol 27 2009 1160 1167
15. A. Zisman Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559 4566 (Pubitemid 35402959)
16. R. Zigeuner, G. Hutterer, and T. Chromecki et al. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology Eur Urol 57 2010 102 111
17. A. Adamy, K.T. Chong, and D. Chade et al. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma J Urol 185 2011 433 438
18. N. Kroeger, T.K. Choueiri, and J.-L. Lee et al. Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy Eur Urol 65 2014 1086 1092
19. M. Gerlinger, A.J. Rowan, and S. Horswell et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
20. M.J. Ellis, and C.M. Perou The genomic landscape of breast cancer as a therapeutic roadmap Cancer Discov 3 2013 27 34
21. Cancer Genoma Atlas Network Comprehensive molecular portraits of human breast tumours Nature 490 2012 61 70
22. S. Puvvada, S. Kendrick, and L. Rimsza Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma Cancer Genet 206 2013 257 265
23. A. Sadanandam, C.A. Lyssiotis, and K. Homicsko et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy Nat Med 19 2013 619 625
24. E.M.F. De Sousa, X. Wang, and M. Jansen et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions Nat Med 19 2013 614 618
25. B.I. Rini, M. Zhou, and H. Aydin et al. Identification of prognostic genomic markers in patients with localized clear cell renal cell carcinoma (ccRCC) [abstract 4501] J Clin Oncol 28 Suppl 2010